Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

BioMarin's Roller Coaster Continues

TheMotleyFool

0 0

BioMarin's Roller Coaster ContinuesPhoto, wide shot, wide-angle lens, Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png

BioMarin Pharmaceutical's (NASDAQ: BMRN) second-quarter earnings report was a bit of a mixed bag, with some drugs growing, some on their typical roller-coaster ride, and earnings slipping due to increased spending on research and development.

While short-term investors may be a bit disappointed, long-term shareholders should look past the quarterly noise, as management reaffirmed 2019 guidance.

Metric

Quelle Fool.com

Like: 0

BMRN

Teilen